Holen Sie sich die Stockscreener-App
0.4107
3.90%
0.0154
Handel nachbörslich:
.41
-0.0007
-0.17%
Schlusskurs vom Vortag:
$0.3953
Offen:
$0.41
24-Stunden-Volumen:
2.03M
Relative Volume:
1.26
Marktkapitalisierung:
$19.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.65M
KGV:
-0.2459
EPS:
-1.67
Netto-Cashflow:
$-24.14M
1W Leistung:
+5.42%
1M Leistung:
-41.48%
6M Leistung:
-78.83%
1J Leistung:
-58.12%
1-Tages-Spanne:
$0.39
$0.411
1-Wochen-Bereich:
$0.38
$0.42
52-Wochen-Spanne:
$0.30
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Firmenname
Reviva Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
(408) 501-8881
Adresse
10080 N WOLFE ROAD, CUPERTINO
Vergleichen Sie RVPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.4107 | 26.49M | 0 | -37.65M | -24.14M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-08 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Eingeleitet | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten
What analysts say about Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockOutstanding risk-reward balance - Autocar Professional
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant a good long term investmentTurbocharged investment results - jammulinksnews.com
Is Reviva Pharmaceuticals Holdings Inc. a good long term investmentMassive profits - jammulinksnews.com
What drives Reviva Pharmaceuticals Holdings Inc. stock priceExceptional portfolio growth - jammulinksnews.com
What drives Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock priceFree Trend-Following Techniques - jammulinksnews.com
What makes Reviva Pharmaceuticals Holdings Inc. stock price move sharplyFree Professional Trading Signals - Newser
What analysts say about Reviva Pharmaceuticals Holdings Inc. stockRapid wealth creation - jammulinksnews.com
Reviva Pharmaceuticals Holdings Inc. Equity Warrant Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
Reviva Pharmaceuticals Holdings Inc. Stock Analysis and ForecastStrongest growth potential - Autocar Professional
Can Reviva Pharmaceuticals Holdings Inc. stock recover from recent declineControlled Risk High Reward Plan - Newser
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs during market volatilityWealth Building Stock Portfolio - Newser
Why Reviva Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionFree Consultation - Newser
What makes Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock price move sharplyFree Stock Market Entry & Exit Signals - Newser
Reviva Pharmaceuticals Holdings Inc: Analyzing RVPH Stock Trends - investchronicle.com
Why Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock attracts strong analyst attentionSmall Risk Large Return Trades - Newser
How Reviva Pharmaceuticals Holdings Inc. stock performs during market volatilityReal Time Stock Signal - Newser
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Reviva Pharmaceuticals’ (RVPH) Buy Rating Reaffirmed at D. Boral Capital - Defense World
Reviva Pharmaceuticals Makes A $10 Million Stock Offering Move - Finimize
Reviva Pharmaceuticals (RVPH) Maintains Buy Rating and Price Tar - GuruFocus
Reviva Pharmaceuticals (RVPH) Launches $10M Public Offering - GuruFocus
Dow Surges 200 Points; US GDP Contracts 0.5% - Benzinga
Reviva Pharmaceuticals (RVPH) Announces Public Offering of Commo - GuruFocus
Reviva Pharmaceuticals (RVPH) Declines After Announcing Public Offering - GuruFocus
Reviva Pharmaceuticals announces public offering of common stock By Investing.com - Investing.com Nigeria
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Consensus Rating of “Buy” by Brokerages - Defense World
Ameriprise Financial Inc. Takes $84,000 Position in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) - Defense World
RVPH: Open Label Extension Results & Key Opinion Leader Discussion - MSN
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):